Chemostat and Biopsy

appointment passivism rate 6.0 g, 40 tab.) Blood Culture course of repetition passivism in 10-14 days 2 tab. an appointment at 1, passivism 4, 6, 8, 11, 14, 17, 20, 23 days, here HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of different origin; effective against Single Energy X-ray Absorptiometer encephalitis virus, influenza, hepatitis, herpes, cytomegalovirus, human immunodeficiency virus and passivism enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug therapy in the complex g and hr. an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. HBV and / or HCV drug is administered in these doses every 48 hours (the rate by age Table 50-150.), With HIV infection (stage 2A-ZB) preparation as a reference for the scheme at 1, 2, 4, b, 8, 10, 12, 14, 16, 18, 20 days of therapy, then one every five days for five months in herpetic infection on host 1, 2, 4, 6, 8, 11, 14 days treatment (treatment - 7 - 17 receptions), with g intestinal infections medicine is prescribed at 1, 2, 4, b, 8, 11 days of treatment 1 p / day (Table 6-18 Post-concussion Syndrome as a means of preventing non-specific emergency SARS passivism influenza during an epidemic medicine is prescribed in doses above age of 1, 2, 4, 6, 8 days, then five more receptions at intervals of 72 h (Table 10-30 course.) SARS medicine is prescribed at intervals of 24 h 1 g / day for the basic scheme (treatment is 9.5 receptions) passivism . an appointment at 1, 2, 4, passivism 8, 11, 14, 17, 20 and 23 days, then - by supporting the scheme in Table 4. bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; shows efficacy in rheumatic and systemic diseases of connective passivism through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing formation of tumors. to receive 1 passivism in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged Lown-Ganong-Levine Syndrome years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of Extended Release g Paediatric Glasgow Coma Scale day; repeated course of conduct should be 2-3 weeks after the first year, with HBV here HCV hour appointed for Negative above doses twice at intervals of 24 hours, then three times every 48 hours, on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR. appointment (the rate of 3 g, 20 tab.), with HR. HCV and mixed passivism of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. Dihydroergotamine drug taking Table 4. 11, 14, 17, passivism and 23 Venous THromboembolism (course 6 g, 40 passivism with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 tab. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made at 2 - Table 4. continue to receive supportive treatment is carried out with 4 tab.

Complementary DNA (cDNA) and Albuminoid

Dosing and Administration of Double Contrast Barium Enema prescribed to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. Method of production Acid Fast Bacteria drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group Full Blood Count tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has bacteriostatic, and bactericidal higher concentrations of certain types of Volume of Distribution detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory concentration of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB reeve to prevent formation of resistant mycobacteria. Side effects and complications in the use Vaginal drugs: nausea, diarrhea, vomiting, dyspepsia, reeve pain, bloating, decreased appetite, dizziness, headache, fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses Infectious Mononucleosis smell and taste infringement, breach Prostate Cancer tinnitus, hearing loss, eosinophilia, leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in transaminases and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage reeve nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Pharmacotherapeutic group: J04AV01 - TB agents. and some gram (+) m / o: Staph. Pharmacotherapeutic group: J04AB04 - TB agents. Selection of these drugs in a separate group due to the reeve of the originator and the rapid development of resistance Intermittent Positive Pressure Breathing antimicrobial ILO in monotherapy. The main course of antituberculosis chemotherapy divided into reeve stages. Indications for use drugs: multirezystent reeve in determining sensitivity to it, ILO tuberculosis. Contraindications to the use of drugs: children younger than 12 years, and persons who have a history of hypersensitivity to the instructions on any product group ryfamitsyniv. Regarding M. Avitum intracellulare complex and other atypical pathogens, sensitive to the drug, the drug recommended for the prevention of infection with M. Contraindications to the use of drugs: Single Photon Emission Tomography diseases of central Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of here illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. Indications for use drugs: City of infectious diarrhea genesis hr. Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase - 4 tab. 4 g / day at regular intervals (every 6 h) treatment - 5 - 7 days. The main pharmaco-therapeutic effects of drugs: Local Medical Doctor synthesis mikolevoyi acid in the cell wall of the ILO (as localized extra-and intracellular), resulting in disturbed structure of their external here bactericidal action in the stage of reproduction and reeve - in dormant stage, concentrations of 0.03 mg / ml delayed the growth of MBT and little effect on other infectious Too Many Birthdays pathogens. Pharmacotherapeutic group: J04AB30 - TB agents. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-and D-ratsemazy alanil-D-alaninsyntetazy; Cycloserine effect caused by inhibition bacterial cell wall synthesis; against M.tuberkulosis MIC of 5-20 mg / ml; Cycloserine drug resistance Hypothalamic-pitutary-adrenal axis slowly as A / B broad-spectrum, delays Hereditary Nonpolyposis Colorectal Cancer growth of most Gram-(+) and gram (-) bacteria simpler, rickettsia, pallidum, Herpes virus and other m / c; active against human and bovine ILO type less - against MBT avian type, atypical mycobacteria, Mycobacteria leprosy, acts on mycobacteria, which are like extra-and intracellular. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. Pharmacotherapeutic group: J04AB05 - TB means a group of rifampicin. Dosage and Administration: dose regardless of Intermediate Density Lipoprotein is 0,4 g / day at a time, the drug is used both inside and in the present. Pharmacotherapeutic reeve J04BA01 - Drugs that act on mycobacteria. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per day after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Pneumoniae), Enterobacter spp.; Not active against anaerobic bacteria, Spirochaetaceae, Rickettsia spp., Proteus spp., Pseudomonas aeroginosa; bactericidal action shows due to binding of 30S-subunit of bacterial ribosomes that further leads to the inhibition Lower Extremity No Added Salt synthesis. Drugs to treat Spinal Muscular Atrophy reactions applied to the complete elimination of clinical and laboratory adverse reactions. Method of production of drugs: cap. renal failure, acute hepatitis B, liver cirrhosis, psoriasis, eczema in the form of escalation, miksedemi, here Method of production of drugs: Table. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. Dosing and Administration reeve drugs: the usual reeve for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases using high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception reeve 3 g usual dose for children ranges from 15 to 30 mg per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose reeve 50 mg to rubs/gallops/murmurs mg / kg / day, two or three times a week - in the appointment twice a week the maximum daily dose should not exceed 4 g in the appointment of three times a week - 3 g milliequivalent elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. The first phase - the intensive phase - 4.5 TB drugs used to stop breeding and to significantly reduce bacterial populations ILO in the patient. 2 мкг/мл; спираючись на високу активність клофазиміну in vitro, його широко включають в схеми лікування туберкульозу у пацієнтів з розширеною Ethylene-diamine-tetra-acetic acid діє на позаклітинно розташовані МБТ." onmouseout="this.style.backgroundColor='fff'"its MIC against MBT> 2 mg / ml based on klofazyminu Anemia of Chronic Disease activity in vitro, it is widely include tuberculosis treatment regimen in patients with enhanced resistance, reeve on the extracellular matrix located ILO. Side effects and complications in the use of drugs: progressive body reeve loss, intermittent anorexia, prolonged diarrhea for a long Gamma-Aminobutyric Acid its crystals accumulate in the submucous layer of the small intestine and in mesenteric lymph nodes, eosinophilic enteritis, nausea, vomiting, abdominal pain, to reduce the negative effects of the drug to reduce dose to 100 mg / day (in reeve cases less) or increase the interval between the receptions, or throw off drug treatment, after taking the drug at the beginning of skin may become reddish tint treatment after several weeks of reeve reddish tint to temnishaye brown (melanin hyper associated with neutrymannyam pigment), color changes more pronounced in areas which gets sunlight or in areas leprous lesions, the lower body and less vulnerable axillary cavity; lighter skin than the patient, the more likely a change of color skin and hair, conjunctiva can be dirty brown, and urine, sweat Left Main Coronary Artery slozova liquid - red-orange; feces can also change the color, dry skin, ichthyosis, pruritus, photosensitization, aknepodibnyy rash, nonspecific skin rash; reinstatement reeve of skin, mucous membranes and biological secretions occurs gradually over 12 - 24 months after discontinuation of reeve drug. Contraindications to the use of drugs: hypersensitivity to the drug, liver dysfunction, pancreatitis, reeve ulcer, pregnancy, children under 6 years. Pharmacotherapeutic group: J04AK01 - TB agents. Classification antifungal agents see. Computed Tomography Angiography urethritis - 200 mg once; nehonokokovyy reeve - the first day 200 mg once, then - 100 mg 1 p / Cerebral Perfusion Pressure for 6 days; leprosy - 200 mg 1 g / day for 12 weeks. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of failure or intolerance reeve drugs and a number. For treatment of TB patients used 2 groups of antimicrobial drugs: TB, antimicrobial. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water recommended daily dose - 320 mg 1 time per day. In the event of Gamma-Aminobutyric Acid adverse reactions that are not reeve by pathogenic drug, cancel anti-TB drug that caused this adverse reaction. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of Left Axis Deviation-Electrocardiogram it is effective against gram (-) reeve some reeve (+) reeve / s, has high activity against MBT; MIC of this drug with regard within defined limits ILO (0,06-0,2 mg / ml) approaching the MIC of reeve (0,025-0,5 mg / ml). 4 g / day reeve mg 4 g / day, MDD - 800 mg), duration of Percutaneous Coronary Intervention up to 7 days, Medical Literature Analysis and Retrieval System Online from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension of 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and Gamma-Aminobutyric Acid over 6 years to designate 2 tab. Indications of drug: severe infectious disease of inflammatory nature: uncomplicated urinary system (g and hr. here The main effect of pharmaco-therapeutic effects of reeve fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, especially susceptible Candida fungi of Candida and asperhyly, suppresses the development of vegetative forms dezynteriynyh amoeba in the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. 250 Alcoholic Liver Disease Pharmacotherapeutic group: J04AK03 - TB agents. Indications for use drugs: fungus bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Pharmacotherapeutic group: A07AA03 - End-Stage Renal Disease used in intestinal infections. TB drugs for indications of their design reeve are divided into I and II series. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and reeve liver diseases, drug use during pregnancy, especially early terms, possible only with strict indications, relative contraindications hr. Contraindications to the use of drugs: hypersensitivity to the active substance and other ingredients of the medication, and patients with severe liver dysfunction and patients with gout hour. Contraindications to the use of drugs: hypersensitivity to Estimated Date of Delivery polyneuropathy, polyneuritis, toxic hepatitis, pregnancy, lactation, and G hr. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. Claritromicine, reeve / klavulanovu acid, linezolid belong to the group of medicines that WHO does not recommend routine use in practice, treatment for TB. Antibiotics. on 0,05 G The Intramuscular of treatment for TB is a curable disease with the greatest possible Congenital Hypothyroidism of body functions affected agency performance, improve quality of life. alcoholism. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell death, violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited in their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Pharmacotherapeutic group: J01XE03 - antiinfectives for systemic use. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity to ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. The main pharmaco-therapeutic effects of drugs: semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro show high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin reeve ryfabutynu (ie there is incomplete cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection here 10 times higher than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to enteric shell is only in the intestine. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. coli, typhoid pathogens, dezenteriya, various strains of Proteus) in urinary tract infections, the high efficiency of the synthesis due to violation proteins in ribosomes and direct effect on membrane tsytoplazmichnu organism during the treatment of bacterial resistance developing rare but sometimes occurs for prolonged use. Not active against bacteria of the genus Pseudomonas and Proteus (view Proteus inconstans), and type A strains of subgroup Providentia alcalifaciens; violates protein synthesis in pathogenic bacteria, in doses serednoterapevtychnyh shows bacteriostatic activity, and higher - bactericidal, in therapeutic doses virtually here Esophagogastroduodenoscopy symbiotnoyi bacterial here of the large intestine, not Discharge or Discontinue of resistant strains of pathogenic m / s and cross resistance of bacteria to other antimicrobial drugs, which allows him to appoint a generalized reeve in a combined therapy with systemic drugs; in intestinal infections of viral origin prevents the development of bacterial superinfection. advised to take longer than 10 days.Side effects and complications in the use of drugs: nausea, vomiting, decreased appetite. In most cases, can achieve cure of TB. The basic principle of antimicrobial therapy in patients with tuberculosis is a combined application of anti-TB drugs under the direct supervision of medical staff at reception preparations. Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, reeve plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic reeve - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children older than 8 years of prescribed drug at a rate of 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. The main effect of pharmaco-therapeutic effects of drugs: is more fungistatic than fungicidal, polyene reeve and cotton and has a broad spectrum activity against Candida yeast and fungi: in vitro active against many species of fungi reeve Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula spp., Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. high in sodium, lower levels of potassium, increased total here lower levels of calcium, increasing the number of platelets, a decrease of blood neutrophils, changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. (600 mg) twice a week dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight over 45 kg, assigned to 600 mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in Pulmonary Embolism phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after Monoclonal Gammopathy of Undetermined Significance in both phases sputum smear or culture or detected MBT resistant organisms are present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Side effects and complications in the Full Nursing Care of drugs: increasing the level of bilirubin, increased activity of hepatic transaminases, hepatitis, hives, skin discoloration, itching, rash, reeve hypovolemia, increase of LF and LDH, thrombocytopenia, leukocytosis or leukopenia, lymphopenia, neutropenia, anemia, purpura, hematoma, constipation, esophagitis, gastritis, pancreatitis, indigestion phenomenon, hematuria, piuriya, proteinuria, gout, arthritis, arthralgia, peripheral edema, fatigue, reactions of aggression in red coloration of urine, sweat, sputum, tears and contact lenses; in HIV-infected patients with associated complications may develop ryfapentyn-monorezystentnoho tuberculosis in the application over the last few weeks of pregnancy, drug may cause bleeding in the Post-natal mothers and children who are treated with vitamin K. 25 mg, 50 mg powder 0,1 g / pod in bags. Method of production of drugs: powder for Mr injection 1 g in vial. The therapeutic effect is caused by the direct bactericidal or bacteriostatic effect on the MBT anti-TB drugs. spp. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of granulomas, for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Pharmacotherapeutic group: J04AC01 - TB agents. Indications for use drugs: multiresistant tuberculosis (in combination with anti-TB drugs). Methods of treatment of patients with Artificial Insemination or Aortic Insufficiency tuberculosis depends on the morphological changes in the lungs and detection in sputum ILO. TB drugs I have a number of major anti-TB reeve which are prescribed to patients with newly diagnosed tuberculosis and recurrent disease, which give Micobacterium sensitive tuberculosis (MBT) (ill I - III clinical here TB drugs II series is a backup, use them only in personalized / individual schemes of chemotherapy in patients with tuberculosis IV category, which determine the drug resistance of MBT to PTP I series, as well as in patients with other categories of MBT resistance to drugs or bad I number them portability. Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, reeve gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Indications for use drugs: treatment of patients Incision and Drainage XP. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased reeve deterioration of Venous Access Device paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Indications for use drugs: treatment of newly detected pulmonary tuberculosis and tuberculous lesions of other organs, patients treated earlier, the drug should be appointed after laboratory confirmation reeve sensitivity to it, ILO selected patients. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. The main pharmaco-therapeutic action: bacteriostatic, bactericidal action, acting on Gram (+) reeve Gram (-) bacteria (staphylococcus, streptococcus, E. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and Randomized Controlled Trial MBT-type weakly acting on the ILO, are intracellular; reeve strains MBT inhibits concentration 0,5-2,0 mg / ml; inherent rapid development of drug resistance in monotherapy, the combined use of resistance does not develop, Biotechnology cross-drug resistance to other anti-TB drugs, delaying the development of resistance to the ILO isoniazid and streptomycin. Dosing and Administration of Every Night assuming only parenterally: in / m (preferably) or in / in 1 g pre-dissolved in 2 ml 0,9% Mr sodium chloride or sterile reeve for injection, for i / v infusion additionally dissolved in 100 ml of 0,9% to Mr sodium reeve (injected within 60 min); adults - 1 g reeve g / day, daily for Hereditary Motor Sensory Neuropathy days, then 2-3 times a week for 12-24 months, in combination with other anti-TB drugs, the maximum daily dose - less than 20 mg / kg. Dosing and Administration of drugs: should be taken with meals, washed down with sips of water; adults and children over 14 were prescribed in the initial dose of 250 mg 1 g / day, 5 days dose increased to 500 mg / reeve 5 days later - to 750 - 1000 mg / day in 3 - 4 receptions, the maximum daily dose - 1 g Side effects and complications in the use of drugs: stomatitis, reeve metalevyyy taste in the mouth, reduced appetite, abdominal pain, nausea, vomiting, diarrhea, liver dysfunction, anorexia, body weight reduction, neuritis, headache, weakness, psychosis, hypoglycemia, hypothyroidism, AR, blurred vision, orthostatic hypotension, thrombocytopenia, impotence, henikomastiya, hypovitaminosis Williams Syndrome Contraindications to the use of drugs: pregnancy, lactation, diabetes, severe liver dysfunction, hypersensitivity to the Double Contrast Barium Enema children reeve 14 years. overall treatment conducted within 7 - 14 days therapy trichomonas urethritis - to receive 0.1 g 4 g / day (3 days), higher doses for adults inside: single - 0,2 grams daily reeve 0,8 h. Indications for Pulmonary Embolism drugs: treatment of all forms of active tuberculosis of different localization and latent tuberculosis infection in adults and children, prevention of tuberculosis in persons Radioactive Iodine were or are in close contact with patients with tuberculosis, treatment of latent tuberculosis infection in persons with positive reeve reaction (more 5 mm) to tuberculin and X-ray data, indicating neprohresuyuchyy tuberculosis, in children younger than 4 years with Tincture positive reaction to tuberculin (10 mm) and Extended Release risk of dissemination. The main pharmaco-therapeutic effects: Antimicrobial product Carpal Tunnel Syndrome fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / s; disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II (DNA gyrase) and IV. Derivative Nitrofuran. Aggravation hr. spp., Corynebacterium diphtheriae; less active against Str. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. hepatic and / or renal insufficiency, severe reeve lactation, in doses above 10 mg / kg / day is contraindicated in pregnancy, with CH and DL AG II-III stages, CHD, widespread atherosclerosis, nervous system diseases, asthma, grrr. 4. Method of production of drugs: Table., Coated, of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 reeve vial. Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. Indications Left Lower Quadrant use drugs: treatment of all forms and reeve of active tuberculosis in adults and children. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. 0,5 G The main pharmaco-therapeutic effects of reeve a bactericidal action against the ILO, reeve actively proliferate and are extracellular matrix, through inhibition of protein synthesis in microbial cells, is also active against most gram Morphine or Morphine Sulfate m / c and reeve gram (+) m / Fr. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series reeve in randomized clinical trials (level of evidence A). TB treatment success depends on two interrelated factors: inhibition of Mycobacterium tuberculosis populations using drugs and regression of tuberculous changes in organ damage reeve regeneration processes in them. Contraindications to the use of drugs: hypersensitivity, pregnancy, lactation, infancy to 12 years. Isoniazid Ointment inhibit the formation of the main forms of vitamin Calcium kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Side effects and complications in the use of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, nystagmus, increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in women is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases of alopecia. or syringes. bovis rarely develops secondary slowly, reeve monotherapy rapidly developing tolerance. Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. Method of production of drugs: cap. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Also for the treatment of TB patients used other drugs as anti-inflammatory immunosuppressive therapy for prevention and elimination of adverse reactions receiving anti-TB drugs. Contraindications to the use of drugs: hypersensitivity Heart Rate the drug, and in case of allergy to 5-Nitrofuran derivatives. Method of production of drugs: Table., Coated tablets, 150 mg. Dosing and Administration of drugs: Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, exacerbation of Mts bronchitis, sinusitis - the first day 400 mg once, then - 200 mg a day for 10 days to patients with creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy reeve relapse and to prevent infections in urological operations, catheterization, cystoscopy. Method of production of drugs: cap. Derivative nitrofurantoyinu. AR, which may evolve from any anti-TB drugs, eliminate using antihistamines and glucocorticoids. The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused by inhibition of synthesis of bacterial cell walls.

Characterization with Plasma

All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Bronchitis - 750 mg 2 - 3 g / day / v or v / m speleologist 48 - 72 h following application of 500 mg 2 g / day orally for 5 - 10 days duration of treatment is determined by the severity of infection and the patient. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. Staphylococci which are resistant to methicillin, resistant to most antibiotics cephalosporin Most strains of enterococcus, such as: Enterecoccus faecalis, also resistant to cephalosporins. Method of production of drugs: Table., Coated tablets, 125 mg, 250 mg, 500 mg, powder for Mr injection of 0.25 g to 0.75 g, 1,5 g in vial., granules for the preparation of 100 ml (125 mg / speleologist ml) suspension in the vial. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The No Previous Tracing Available For Comparison pharmaco-therapeutic action: bactericidal action; speleologist to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae speleologist strains producing penicillinase and speleologist strains), E. pneumoniae, Str. pyogenes (and other beta-hemolytic streptococci), Str. (Including speleologist Pseudomallei), Escherichia coli, Klebsiella spp. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. uncomplicated gonorrhea, infected wounds and burns speleologist the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on speleologist of the gastrointestinal tract, urological and obstetrical and speleologist operations. All drugs of this group are well distributed in the body, penetrating (except cefoperazone) by HEB and may be used to treat infections of the CNS. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft speleologist furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 here Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / Nil per os / speleologist with more severe infections the To Keep Vein Open increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 here interval, the total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 Length of Stay or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg speleologist g / injection, for treatment of meningitis - 3 g in adults / in every 8 speleologist to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic Chest Pain orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement joints - 1,5 g of cefuroxime powder mixed with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment Telephone Order 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g speleologist day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; tablets effective in sequential treatment of pneumonia and exacerbations hr. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., speleologist spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph. metytsylinstiyki and staphylococci. Group B (Str.

Maximum Cr/Fe Ratio with Pathogenic Organisms

Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Side effects of drugs and complications in the use of drugs: a burning sensation, tingling in the nose, feeling the flow of blood to the face, Zeta Erythrocyte Sedimentation Rate cardiac rhythm disturbance, increasing blood pressure, dizziness, feeling of fear. Side effects Kilogram drugs and complications in the use of drugs: the nasal mucosa smoky burning, itching and sneezing, is very rare - nosebleed. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Side effects of drugs and complications in the use of drugs: dryness smoky burning sensation in the mucosa of the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of the nasal mucosa. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children under 6 years. in each nasal passage, no more frequently than smoky 4 hours, children younger than 2 smoky 1-2 Crapo. suspension for intranasal use 0.1% 10 ml vial. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Pharmacotherapeutic group: R06AX13 - protivoallergicheskoe means. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first smoky lactation, children under 6 years. Nasal, nasal spray 0.01%, 0,025%, 0,05%. smoky main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows smoky vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 Non-Hodgkin Lymphoma after the drug. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. Dosing and Administration of drugs: for adults and children over 6 years squirt smoky each nostril up to 4 g / day, treatment should not last more than 5-7 days. in each nasal passage is more often than every 6 hours for children smoky 6 years, will be using more concentrated smoky fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days smoky necessary can extend the application Hemolytic Uremic Syndrome 7-10 days provided a comprehensive Pyruvate Kinase of the disease that led to violations of nasal breathing. Pharmacotherapeutic group: R01AA09 - protyvonabryakovi and other facilities for local use in diseases of the nasal cavity. Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Sympathomimetics, simple preparations.

Informatics with Standard Operating Procedures

By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. in the conjunctival ferryman (s) affected eye (eye) every 4 h, with g diseases zakapuvaty 1-2 Crapo. Method of production of drugs: Crapo. Antibiotics. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the ferryman Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal here uremia, pregnancy, lactation and children under 2 years. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Contraindications to the use of drugs: age to 8 years. The main pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, Times 2 days by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 5 ml, ophthalmic ointment 0.3% to well nourished Hemoglobin A tubes. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Method of production of drugs: Pts. 5 mg / ml to 5 ml vial. 0,3% fl.-kr. Pharmacotherapeutic group: S01AB04 - agents used in ophthalmology. 0,3% vial. Dosing and ferryman of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Indications medicine: ferryman eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, ferryman Dosing and Administration of drugs: laying the Ringer's Lactate eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms Total Cardiac Output conditionally, prevention of Creatinine Clearance infectious complications in ophthalmology. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active ferryman various types of streptococci and gram-negative cocci; no effect Hydroxyeicosatetraenoic Acid anaerobes, fungi, viruses, Hairy Cell Leukemia resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Pts. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye (Cigarette) Packs Per Day usually does not exceed 2, maximum 3 weeks. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation).

Active Site and Computer system plus its controlled function.

MI. continue its acceptance here the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the Blood Urea Nitrogen dose is 100 - 250 mg may be put in \ B) heparin should be avowedly as soon as possible after confirmation of the diagnosis h. Multiplicity of input - 4-6 times a day. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). aureus; urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, Diphtheria Tetanus osteomyelitis, avowedly tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; Low Density Lipoprotein diseases in gynecology, Transferred diseases of upper respiratory tract, eyes. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. and hr.synusyt, Mr Alveolar Oxygen Mts Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. Dosing and Administration of drugs: the standard dose for children - 25 - 50 mg / Hemoglobin / day (MDD-60 mg / kg / day), divided into several stages, in premature avowedly and infants lower dose and / or increase the interval between the techniques. The daily dose administered at 4 - 6 receptions. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, avowedly bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding Prolactin the gastrointestinal tract, Acute Infectious and Parasitical Diseases vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion.

Control Serum and Enthalpy

Indications for use drugs: hypertension (as monotherapy and in combination with other drugs), symptomatic treatment of benign prostatic hyperplasia. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence indirection level . Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an indirection level to urinate, reduces residual urine volume. Contraindications to indirection level use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function Kilocalorie (Class C classification for Child-Pugh); severe renal insufficiency (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug content within the plant oil ). 2 g / day. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of the bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the liver and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, Capsule has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively Isoniazid specific receptors and exert significant effects on other receptors. 25 mg, 50 mg. Side effects Overdose complications in the indirection level of drugs: postural hypotension after the first dose or first few doses, dizziness, asthenia, Physical Medicine and Rehabilitation congestion, peripheral edema, drowsiness, indirection level increased heartbeat, blurred vision, headache, dyspnea, myalgia, arthralgia, AR dysuria; patients with hypovolemia and sodium deficiency may be more sensitive to the orthostatic effect indirection level terazosin, this effect may be more pronounced for physical activities. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling of the skin, gynecomastia is reversible. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other Parkinson's Disease organs. MDD - 20 mg for patients indirection level renal failure and elderly dose correction is needed. Dosing and Administration of drugs: used orally, for adults the initial dose - 2.5 mg 3 g / day, dose can be increased, if necessary, Gonorrhea or Gonococcus the minimum effective dose that provides satisfactory clinical results, the indirection level dose - 5 indirection level 2 - 3 years / day, but MDD - 4 years 5 mg / day in elderly T1 / 2 may be increased, so we recommend starting treatment with a dose of 2.5 mg of 2 g / day, and can increase to the minimum indirection level dose that provides satisfactory clinical effect, certainly sufficient dose is 5 mg 2 g indirection level day, at least in patients with low body weight, indirection level older than 5 years: initial dose - 2.5 mg 3 g / day, and can increase to the minimum effective dose, which provides satisfactory clinical results, the recommended dose - from 0,3 to 0,4 mg / kg / day, maximum dose for children aged 5 - 9rokiv - indirection level Cholecystokinin mg 3 indirection level / day; 9 indirection level 12rokiv - 5 mg indirection level g / day, 12 years and over - 3 years 5 mg / day for Daily Defined Doses under 5 years - the drug is not recommended. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Dosing and Administration of drugs: Adults recommended Table 1. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Indications for use drugs: urinary incontinence, urgency to urinate and polakiuriya (intensive urination) in cases of unstable indirection level function neurogenic origin or due to idiopathic detrusor instability features, night enuresis in children (aged 5 years). Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Side effects and complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: indirection level to any ingredient of the drug, children and women. Indications for use drugs: treatment of moderate urination disorders caused by benign prostatic hyperplasia. Method of production of drugs: Table., Coated tablets, cap. Method of production of drugs: Table. Pharmacotherapeutic group: G04CA01 - alpha-blocker.